| 
				
				Re: Allostim
			 
 This company is trialling their product in thailand and are charging people a huge amount of money >$40,000 for phase 1/2 i.e they have not proven efficacy.  I was in contact for a while with someone in it unfortunately it did not work for his wife.
 The research had been done in Israel they had open a trial in the state but were shut down.. and now are abroad charging cancer patients a fortune.
 
				__________________  
35 y/o 
June 06: BC stage I 
Grade 3; ER/PR neg
Her-2+++; lumpectomies 
Aug 06: Stage IV 
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006 
NED til Oct 09 
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised.. 
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo.. 
  
superior vena cava blocked:  stent but face remains puffy
  
April 2012: Teresa Trial, randomised to TDM1 
Nov 2012 progressing on TDM1 
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes. 
  
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
 
 
  
'Under no circumstances should you lose hope..' Dalai Lama
			 |